Stilwell McDavid 4
4 · Coherus BioSciences, Inc. · Filed Apr 30, 2021
Insider Transaction Report
Form 4
Stilwell McDavid
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-04-28+50,000→ 50,000 totalExercise: $14.76Exp: 2031-04-28→ Common Stock (50,000 underlying) - Award
Common Stock
2021-04-28+20,000→ 30,000 total
Footnotes (3)
- [F1]Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/2 of the RSUs vest annually on April 1 of each year, with the first 1/2 vesting on April 1, 2022 and with the RSUs being fully vested on April 1, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
- [F2]Includes 30,000 RSUs.
- [F3]The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from March 8, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.